Provided By GlobeNewswire
Last update: Mar 20, 2025
Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth
Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and integrate seamlessly with Renovaro Biosciences
Read more at globenewswire.comNASDAQ:POAI (6/17/2025, 2:51:45 PM)
0.91
-0.05 (-5.21%)
Find more stocks in the Stock Screener